<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
	<channel>
		<title>Industry News | LabMedica International</title>
		<description><span style="font-size: 11pt; font-family: 'Comic Sans MS';"><font face="times new roman, new york, times, serif">LabMedica <span style="background: yellow none repeat scroll 0% 0%; -moz-background-clip: -moz-initial; -moz-background-origin: -moz-initial; -moz-background-inline-policy: -moz-initial;">Industry News</span> channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide. </font></span></description>
		<link>https://www.labmedica.com</link>
		<lastBuildDate>Mon, 20 Jul 2026 08:51:54 +0100</lastBuildDate>
		<generator>FeedCreator 1.7.2</generator>
		<item>
			<title>Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition</title>
			<link>https://www.labmedica.com/industry-news/articles/294811949/leica-biosystems-to-expand-pathology-portfolio-through-statlab-acquisition.html</link>
			<description>A new acquisition unifies histology workflows to boost standardization and prepare labs for AI-enabled cancer diagnostics.</description>
			<category>Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition - Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition</category>
			<pubDate>Wed, 15 Jul 2026 16:31:10 +0100</pubDate>
		</item>
		<item>
			<title>Seed Amplification Test Expands Access to Neurodegenerative Disease Testing</title>
			<link>https://www.labmedica.com/industry-news/articles/294811853/seed-amplification-test-expands-access-to-neurodegenerative-disease-testing.html</link>
			<description>Amprion has secured a multi-million-dollar growth investment to expand neurodegenerative disease testing capacity.</description>
			<category>Seed Amplification Test Expands Access to Neurodegenerative Disease Testing - Seed Amplification Test Expands Access to Neurodegenerative Disease Testing</category>
			<pubDate>Wed, 15 Jul 2026 15:17:41 +0100</pubDate>
		</item>
		<item>
			<title>Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing</title>
			<link>https://www.labmedica.com/industry-news/articles/294811871/nateras-signatera-earns-ivdr-certification-for-solid-tumor-mrd-testing.html</link>
			<description>Natera’s Signatera has becomie the first personalized MRD test for solid tumors to achieve IVDR certification in the EU.&amp;#160;</description>
			<category>Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing - Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing</category>
			<pubDate>Fri, 10 Jul 2026 11:52:15 +0100</pubDate>
		</item>
		<item>
			<title>Eurobio Scientific Completes Acquisition of CareDx Lab Products Division</title>
			<link>https://www.labmedica.com/industry-news/articles/294811765/eurobio-scientific-completes-acquisition-of-caredx-lab-products-division.html</link>
			<description>Eurobio Scientific has finalized its acquisition of CareDx’s Lab Products division, expanding its transplantation IVD portfolio.</description>
			<category>Eurobio Scientific Completes Acquisition of CareDx Lab Products Division - Eurobio Scientific Completes Acquisition of CareDx Lab Products Division</category>
			<pubDate>Mon, 06 Jul 2026 11:18:08 +0100</pubDate>
		</item>
		<item>
			<title>Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia</title>
			<link>https://www.labmedica.com/industry-news/articles/294811761/blood-based-crispr-test-for-tuberculosis-gains-regulatory-approval-in-colombia.html</link>
			<description>IntelliGenome receives INVIMA approval for CRISPR-TB blood test and appoints Velez Lab as Colombia distributor.</description>
			<category>Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia - Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia</category>
			<pubDate>Mon, 06 Jul 2026 11:01:39 +0100</pubDate>
		</item>
	</channel>
</rss>
